/Investor DB

BAM Elevate

Institutional investor

Chicago · 5 people tracked

Also known as BALYASNY ASSET MANAGEMENT L.P.

Find your way into BAM Elevate

Each arrow is one introduction. Sign up to fill in the first one.

1 person can intro you to Bill

Ask Yujin Chung to introduce you to Bill Wappler

You →Yujin · together at BAM Elevate →Bill

1 person can intro you to Dmitry

Ask Jamie Chen to introduce you to Dmitry Balyasny

You →Jamie · together at BAM Elevate →Dmitry

1 person can intro you to Dustin

Ask Sam Okafor to introduce you to Dustin Chang

You →Sam · together at BAM Elevate →Dustin

Sign up to find every way you can get introduced to BAM Elevate

  • Your email: who you already know at BAM Elevate, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the BAM Elevate team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Balyasny generates absolute returns in all markets through a blend of core strategies driven by proprietary research. The firm emphasizes bringing together talented teams and business builders to create winning organizations that iterate and improve. The firm's philosophy centers on identifying problems, solving them directly, and maintaining humility while constantly learning and evolving. Partnership is foundational to the firm's approach, both internally across strategies and departments and externally with investors and portfolio partners.

Invests inSector AgnosticChicagoGlobal

Source: firm website, verified Sep 29, 2026.

HQ
Chicago, CA, US
Leads rounds
Follows
Instruments
Equity
Founded
2001
Last 12 months
13 investments
AUM
$248.1B
Tracked investments
28
Unicorns
5
IPOs
4
Acquisitions
1

Team · 5 people

from the firm's website & public directories
Amy Le· Analystin
Dustin Chang· Analystin

What they invest in

from 26 of 28 portfolio companies

AI & Machine Learning ×13Enterprise Software ×9SaaS ×7Biotech ×6Developer Tools ×6Fintech ×4Data & Infrastructure ×3Deep Tech ×3

HQs:United States×19

Investments · 28 tracked

founders shown can be your intro path

By year:2026 · 92025 · 42024 · 22023 · 42022 · 82018 · 128 dated

Damora TherapeuticsNASDAQ: DMRANov 2025 · $284.9M

Damora Therapeutics is a preclinical-stage biotechnology company that discovers and develops therapeutic candidates, including DMR-001, DMR-002, and DMR-003, with the goal of advancing treatments through investigational drug applications and clinical trials.

BiotechCopenhagen, US

Garrett Winslow(Executive Officer)inLori Firmani(Executive Officer)inHans T. Schambye(Executive Officer, Director)Jennifer Jarrett(President, Chief Executive Officer and Director)inBecker Hewes(Chief Medical Officer)Sherwin Sattarzadeh(Chief Operating Officer)

Co-investorsAccess BiotechnologyAndreessen HorowitzBay City CapitalCommodore CapitalEIR VenturesForbion+7 more

Latchlatch.aiinOTC: LTCHAug 2018 · $70M

Latch captures how teams actually work and converts operational context into structured data that AI tools can rely on.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareFuture of WorkSaaS

Stefan KalbinJared KofroninPriyen Patel(Chief Strategy and Legal Officer)

Co-investorsCade VenturesFUSEPioneerPrimary Venture PartnersCamber CreekCorigin Ventures+3 more

Relmada Therapeuticsrelmada.comNASDAQ: RLMDMar 2026

Relmada is a clinical-stage biopharmaceutical company developing therapies including NDV-01, a sustained-release intravesical formulation of gemcitabine and docetaxel for non-muscle invasive bladder cancer, and Sepranolone, a candidate targeting compulsive behaviors via GABAA receptor modulation.

BiotechHealthtechNew York, US

Sergio Traversa(Executive Officer, Director)Paul Kelly(Director)Maged Shenouda(Director)inEliseo O. Salinas(President and Chief Scientific Officer)inDouglas Beck(Chief Financial Officer)Charles Ence(Chief Accounting and Compliance Officer)

Co-investorsBioAdvanceBraidwellCommodore CapitalJanus Henderson InvestorsOrbiMedRA Capital+2 more

Sagimet Biosciencessagimet.cominNASDAQ: SGMTApr 2026 · $175M

Sagimet is a clinical-stage biopharmaceutical company developing therapies targeting fatty acid synthase (FASN) for metabolic diseases and oncology.

BiotechDigital HealthHealthtechMenlo Park, US

Rekha Hemrajani(Executive Officer)inMerdad Parsey(Executive Officer, Director)inDavid Happel(Chief Executive Officer & Director)Andreas Grauer(Chief Medical Officer)inThierry Chauche(Chief Financial Officer)inMarie O'Farrell(Chief Scientific Officer)in

Co-investorsAltium CapitalHM Venture PartnersKleiner PerkinsNew Enterprise Associates (NEA)Biotechnology Value FundBlue Owl Capital+1 more

Ambros Therapeuticsambrostherapeutics.comDec 2025acquired by Werewolf Therapeutics · Aug 2026 · $500M

Ambros Therapeutics is a clinical-stage biotechnology company developing medicines for diseases with high unmet medical need, with a lead program targeting complex regional pain syndrome type 1 (CRPS-1), a rare condition typically following limb injury.

BiotechSan Diego, US

Joseph (Jay) Hagan(President and Chief Executive Officer)

Co-investorsLifeSci Venture PartnersRA CapitalJanus Henderson InvestorsPatient Square Capital

Applied Intuitionappliedintuition.comin𝕏Apr 2026

Applied Intuition develops physical AI software for autonomous and intelligent machines, including vehicles, robots, ships, and satellites across industries like automotive, defense, logistics, and manufacturing.

AI & Machine LearningDeep TechDeveloper ToolsEnterprise SoftwareRoboticsSunnyvale, US

Qasar Younis(Co-founder and CEO)inPeter Ludwig(Co-founder and CTO)in

Co-investors137 VenturesAndreessen HorowitzBond Capital ManagementCatalytic Impact FoundationCoatue ManagementElad Gil+32 more

Arthurarthur.digitalin𝕏Sep 2022 · $42M

Arthur develops an AI-powered platform that enables organizations to build and deploy immersive workflows and experiences combining synchronous and asynchronous collaboration.

AI & Machine LearningEnterprise SoftwareFuture of WorkSan Mateo, US

Christoph Fleischmann(Founder)in

Co-investorsDraper AssociatesPlexo CapitalAcrew CapitalGreycroftHomebrewIndex Ventures+1 more

ArthurAIarthur.aiin𝕏Sep 2022

Arthur provides AI performance monitoring, optimization, explainability, and bias mitigation solutions for enterprise customers deploying artificial intelligence.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareNew York, US

Adam Wenchel(CEO)in

BoardMike Volpi(Director)inTheresia Gouw(Director)inJonathan Lehr(Director)in

Co-investorsAcrew CapitalGreycroftHomebrewIndex VenturesWork-BenchPlexo Capital

Astranisastranis.comin𝕏May 2026 · $300M

Astranis manufactures small, high-powered geosynchronous satellites equipped with advanced digital processing technology for global telecommunications and connectivity services.

Advanced ManufacturingDeep TechHardwareSpace TechSan Francisco, US

John Gedmark(Founder/CEO)inRyan McLinko(Founder/CTO)inMike Mancini(Executive Officer)

BoardMartin Casado(Director)inEthan Batraski(Director)inDan Berkenstock(Director)

Co-investorsAndreessen HorowitzATEL VenturesBlack FlagBoxGroupCantos VenturesCherubic Ventures+84 more

Coultreoncoultreon.cominApr 2026 · $125M

Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.

AI & Machine LearningBiotech

Pierre Raboisson(Chief Executive Officer Chief Scientific Officer Co-founder)inMarie De Vulder(Chief Legal Officer Co-founder)inGuy Peeters(Chief Financial Officer Co-founder)inJohn-Paul Gallivan(Head of Development Co-founder)inFabrice Kolb(Head of Immunology Co-founder)inPieter Peeters(Operating & Technology Officer Co-founder)in

Co-investorsFinchley Healthcare VenturesLongwood FundLuma GroupSofinnova VenturesForbionNovo Holdings+1 more

Crusoecrusoe.aiin𝕏Oct 2025

Crusoe builds energy-first AI infrastructure, using innovative and renewable energy sources to power hyperscale AI factories and a cloud platform for AI workloads.

AI & Machine LearningCloud ComputingData & InfrastructureEnergyDenver, US

Cully Cavness(Co-founder, President and Chief Strategy Officer)inChase Lochmiller(Co-founder, CEO and Chairman of the Board of Directors)inCharles Cavness(Executive Officer, Director)Matthew DeNezza(Executive Officer)inJamey Seely(Executive Officer)inMichael Gordon(Executive Officer)in

Co-investorsAbstract VenturesACTIVATE CAPITAL PARTNERSAdvaita CapitalAir Street CapitalAkkaAlkeon Innovation+69 more

Edge Deltaedgedelta.comin𝕏May 2022 · $63M

Edge Delta provides telemetry pipeline and observability tools for DevOps, IT/Ops, SRE, and Security teams to process logs, metrics, traces, and events at scale without centralizing all raw data.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareSeattle, US

Ozan Unlu(Co-founder)inFatih Yildiz(Co-founder)in

Co-investorsAmity VenturesCisco InvestmentsGeodesic CapitalKin VenturesMaC Venture CapitalMenlo Ventures+3 more

Forterraforterra.comin𝕏Nov 2025 · $238M

Forterra develops autonomous weapons, sensors, and battlefield systems using distributed control networks for defense operations.

AI & Machine LearningDefense TechRobotics

Alberto Lacaze(Chairman of the Board and President)inJoseph Putney(Chief Technology Officer)in

Co-investors645 VenturesCollaborative FundCRESCENT COVE CAPITALEnlightenment CapitalGlynn Capital ManagementNightDragon+9 more

Harnessgoharness.comApr 2022

Harness is a fundraising platform designed for nonprofits to increase donation revenue without expanding staff or software tools.

FintechImpact & Social GoodSaaS

Jyoti Bansal(Founder)in

Co-investorsFlorida FundersAlkeon CapitalBattery VenturesCapital One VenturesCiti VenturesGaingels+8 more

Harnessharnessfi.cominApr 2022

Harness turns financial institutions' raw transaction and member data into real-time, personalized engagement campaigns for card and rewards programs.

Data & InfrastructureFintechMarketing Tech

Co-investorsTruStage VenturesAlkeon CapitalBattery VenturesCapital One VenturesCiti VenturesDeepgram+9 more

Instrumentalinstrumental.financeFeb 2022 · $50M

Strategy hub enabling DeFi yield access across multiple chains and layers for comprehensive cross-chain growth.

Co-investorsAdvanced BlockchainEclipse VenturesRoot Ventures Manager, Llc

Leapleap.energyinJun 2023 · $15M

Leap builds a platform that enables virtual power plant management by connecting storage, electric vehicle, and smart building systems to grid-support energy programs, helping reduce fossil fuel dependence and integrate renewable energy.

AI & Machine LearningCleantechClimate TechEnergySaaSSan Francisco, US

Remco van den Elzen(Co-founder, Leap)inThomas Folker(Co-Founder, Chief Strategy Officer)inNICK GROSSMAN(Director)inJason Michaels(CEO)in

Co-investorsCongruent VenturesPresidio VenturesNational Grid PartnersDNV VenturesFJ LabsGaruda Ventures+9 more

Leapleapwallet.ioJun 2023 · $15M

Leap Wallet is a crypto wallet product serving users across multiple market cycles, built with partners in the blockchain ecosystem.

Crypto & Web3

Co-investorsAccelApis PartnersCostanoa VenturesEqual VenturesJungle VenturesOwl Ventures+1 more

LeapXpert websiteleap.expertin𝕏Jun 2023 · $15M

LeapXpert provides enterprise governance and security controls for messaging platforms, enabling organizations to enforce data loss prevention, information barriers, and compliance policies across channels like Teams and Slack.

CybersecurityEnterprise SoftwareFintechGovTechSaaS

Co-investorsAloniqQBN CapitalApis PartnersCostanoa VenturesEqual VenturesJungle Ventures+2 more

Logiwalogiwa.cominNov 2022

Logiwa IO is a cloud-native warehouse management system designed for third-party logistics providers and fulfillment networks that process high volumes of orders.

AI & Machine LearningEnterprise SoftwareLogistics & Supply ChainSaaSChicago, US

Erhan Musaoglu(CEO)inGreg Halko(COO)inPatrick Bouchard(CRO)in

BoardAnna Garcia(Director)Cenk Bayrakdar(Director)in

Co-investorsLaunchCapitalNewRoad Capital Partners, LLCRunway Venture PartnersSpider CapitalValor Equity PartnersLaunch Capital+2 more

Lycia Therapeuticslyciatx.comin𝕏Jun 2026 · $75M

Lycia Therapeutics is a biotechnology company developing LYTAC (Lysosomal Targeting Chimera) therapeutics that bind disease-causing extracellular and cell-surface proteins and route them into the cell's lysosome for degradation.

BiotechHealthtechSouth San Francisco, US

Carolyn Bertozzi(Lycia founder and Professor of Chemistry, Stanford University)inAetna Wun Trombley(President and CEO)inAmy Bachrodt(Chief Financial Officer)inChin Lee(Chief Medical Officer)inSteve Staben(Chief Scientific Officer)inSofia Touami(Chief Business Officer)in

Co-investorsREDMILEVersant VenturesHBM Healthcare InvestmentsHBM PartnersFranklin TempletonInvus+5 more

OneSignalonesignal.comin𝕏Sep 2022

OneSignal provides customer engagement and messaging infrastructure that enables businesses to send personalized, omnichannel communications to their customers at scale.

AI & Machine LearningCloud ComputingDeveloper ToolsEnterprise SoftwareMarketing TechSaaSSan Francisco, US

George Deglin(Co-Founder and CEO)inLong Vo(Co-Founder and COO)in

Co-investorsCoelius CapitalHemisphere Ventures LLCHubSpot VenturesNewView CapitalNimble PartnersSignalFire+10 more

Poolsidepoolside.aiOct 2024 · $500M

Poolside builds open-weight foundation models and agentic coding models, including the Laguna family, along with the systems and infrastructure needed to train, refine, and improve these models.

AI & Machine LearningDeveloper Tools

Jason Warner(Founder & CEO)inEiso Kant(Founder)

Co-investors20VC7GC & CoAbstraction CapitalAir Street CapitalB Capital GroupB4 Capital+27 more

Saronicsaronic.comin𝕏Mar 2026

Saronic builds autonomous surface vessels — including the 180-foot, long-range Marauder — along with Echelon, a command-and-control software layer for planning, simulating and operating single vessels or fleets.

AI & Machine LearningDefense TechHardwareRoboticsAustin, US

Dino Mavrookas(Co-Founder and CEO)inRob Lehman(Co-Founder and CCO)inVibhav Altekar(Co-Founder and CTO)inDoug Lambert(Co-Founder and COO)inPatrick DePriest(Chief Financial Officer)inSoo Cho(Chief People Officer)in

Co-investors1Flourish Capital8VCAdvent InternationalAlpha PartnersAndreessen HorowitzAnti+34 more

Skyryse Aviation Technologyskyryse.comin𝕏Feb 2026

Skyryse develops SkyOS, a flight-control operating system that simplifies aircraft operation through automated maneuvers, emergency management, and optionally piloted or autonomous flight.

Deep TechDefense TechMobility & TransportationEl Segundo, US

Mark Groden(Founder & CEO)inStephen Koo(Executive Officer, Director)inBlake Bilstad(Executive Officer)in

BoardLior Susan(Director)inWill Summerlin(Director)Ethan Batraski(Director)in

Co-investorsCantos VenturesCity LightDas & Co.Embedded VenturesFlucas VenturesFOG Ventures+24 more

The Honest Companyhonest.comAug 2026

Honest is a consumer brand offering personal care and baby products made with ingredients audited by toxicologists and tested by dermatologists, formulated without synthetic fragrances and marketed as cruelty-free.

ConsumerDirect to ConsumerWellness & FitnessSanta Monica, US

Christopher Gavigan(Executive Officer, Promoter)Brian Lee(Executive Officer, Director, Promoter)inSean Kane(Executive Officer)inJessica Alba(Founder)inCraig Gatarz(Executive Officer)David Parker(Executive Officer)

Co-investorsFarvatn VentureGeneral CatalystICONIQIVP (Institutional Venture Partners)Lightspeed Venture PartnersMisfit Venture Partners+3 more

Treasury Primetreasuryprime.comin𝕏Feb 2023

Treasury Prime provides embedded banking technology through APIs that enable fintechs to embed banking services in their applications.

Enterprise SoftwareFintechSaaSSan Francisco, US

Chris Dean(Co-founder & CEO)inJim Brusstar(Co-founder)in

Co-investorsArdent VentureAZURO CAPITAL VENTURESDeciensFINTOP CapitalGMO VenturePartnersNyca+10 more

Exits · 5

4 IPOs · 1 acquisitions

Damora TherapeuticsNASDAQ: DMRALatchOTC: LTCHRelmada TherapeuticsNASDAQ: RLMDSagimet BiosciencesNASDAQ: SGMTAmbros Therapeuticsacq. by Werewolf Therapeutics

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has BAM Elevate made?
BAM Elevate has 28 tracked investments, 5 of which have exited, including 13 dated in the last 24 months.
What sectors does BAM Elevate focus on?
BAM Elevate focuses on Sector Agnostic.
Where is BAM Elevate located?
BAM Elevate is headquartered in Chicago, US.
Does BAM Elevate lead rounds?
BAM Elevate typically participates in rounds rather than leading them.

Similar investors

3TS Capital Partners

3TS Capital Partners is a European technology-focused growth investment adviser whose advised funds provide growth capital, typically leading or co-leading substantial funding rounds for innovative tech companies primarily in the DACH, CEE and Nordic regions.

$324K – $10.8M
4Di Capital

4DI Ventures was co-founded by repeat tech operator and ESET Southern Africa founder Justin Stanford, giving it unusually deep cybersecurity and software operating experience rather than a purely financial background, and originated from Stanford's own angel-investing experiments that directly led to both the firm's creation and the launch of the Silicon Cape Initiative. The firm explicitly describes its style as "nurture capital" with intensive, hands-on engagement, and Stanford is vocal about avoiding the "unicorn at all costs" mentality in African tech, instead emphasizing sustainable market readiness and fundamentals in a more conservative, durability-focused investment approach.

$100K – $1M
83North

83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.

$100K – $10M
8VC

8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.

$500K – $50M
Accel

Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.

$500K – $100M

Featured in lists